GlaxoSmithKline To Open Access to Clinical Trial Data for ResearchReporting Technology’s Impact on Healthcare
Posted Oct 11 2012 12:00am
GlaxoSmithKline plans to make much of its drug data from clinical trials available to researchers starting in 2013. An expert panel will review information requests from scientists, and then GSK will make the relevant data available on a secure website. Reuters, New York Times.
from iHealthBeat http://feedproxy.google.com/~r/Ihealthbeat/~3/qPm91pxDPrw/glaxosmithkline-to-open-access-to-clinical-trial-data-for-research.aspx